Back to top
more

Perrigo (PRGO)

(Delayed Data from NYSE)

$14.76 USD

14.76
2,602,462

+0.28 (1.93%)

Updated Aug 26, 2026 04:00 PM ET

After-Market: $14.76 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 247)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Perrigo (PRGO) Beats Q2 Earnings Estimates

by Zacks Equity Research

Perrigo (PRGO) delivered earnings and revenue surprises of 0.83% and -3.48%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Equity Research

    Drug/Biotech Stock Q2 Earnings on Aug 9: PRGO, BDSI & More

    by Zacks Equity Research

    Several drug/biotech companies are set to report second-quarter results on Aug 9. Let's see how things are shaping up for their announcements.

      Zacks Equity Research

      What's in the Cards for Perrigo (PRGO) This Earnings Season?

      by Zacks Equity Research

      Perrigo's (PRGO) product purchases and introductions in the Rx segment are expected to boost sales.

        Zacks Equity Research

        Perrigo (PRGO) Misses on Earnings in Q1, Reiterates View

        by Zacks Equity Research

        Perrigo (PRGO) misses earnings estimates but exceeds revenue expectations in Q1. The company reiterates its revenue and adjusted earnings outlook for 2018.

          Urmimala Biswas headshot

          Medical Product Stocks May 8 Earnings List: HSIC, PEN & More

          by Urmimala Biswas

          An important component of the broader Medical sector, the Medical Product space consistently grabs attention owing to a string of upsides.

            Zacks Equity Research

            Is a Beat in the Cards for Perrigo (PRGO) in Q1 Earnings?

            by Zacks Equity Research

            Perrigo's (PRGO) product purchases and introductions in the Rx segment might shoot up sales in the near future.

              Zacks Equity Research

              Why Is Perrigo Company (PRGO) Up 4.7% Since Its Last Earnings Report?

              by Zacks Equity Research

              Perrigo Company (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                Zacks Equity Research

                Stock Market News for March 5, 2018

                by Zacks Equity Research

                Healthy rise in healthcare shares helped the S&P 500 and the Nasdaq finish in the positive territory on Friday

                  Zacks Equity Research

                  Perrigo (PRGO) Surpassed Earnings in Q4, Revenues Down Y/Y

                  by Zacks Equity Research

                  Perrigo (PRGO) posts better-than-expected earnings with revenues also beating estimates. The top line however, drops year over year.

                    Zacks Equity Research

                    Perrigo (PRGO) Postpones Q4 Earnings Results, Shares Down

                    by Zacks Equity Research

                    Perrigo (PRGO) to reschedule fourth-quarter 2017 and full-year earnings results. However, the company releases preliminary unaudited numbers for the full year.